echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Drug belt procurement remodels the industry pattern A large number of pharmaceutical representatives face elimination

    Drug belt procurement remodels the industry pattern A large number of pharmaceutical representatives face elimination

    • Last Update: 2020-05-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Among the varieties purchased in this band, Abitron, Adefoveester, Acapo sugar, amosilin, azithromycin, omesataneste, Sorolol, etcare all large clinical varietiesPing An Securities issued a report that under the influence of band procurement, the profitability of generic drugs fellAccording to the progress of the band procurement, the range of varieties will be gradually expanded in the futurean investor told the Securities Daily reporter, with the volume of procurement recommendations, consistency evaluation and other policies to promote, the pharmaceutical industry's small enterprises to further intensify the elimination, medium-sized enterprises are still waiting, "one is no research and development talent reserves, and also invested in research and development innovation worry about water drift."industry insiders told the Securities Daily reporter, the implementation of the volume procurement will show the normal, but also means that the biopharmaceutical industry pattern adjustment further speed upIt is worth mentioning that "in the compression of the cost of sales, generic drugs into the micro-profit period, enterprises are also facing performance pressure." This has also led to the pharmaceutical representatives facing survival pressure, some pharmaceutical companies have begun to lay off pharmaceutical representatives."band procurement continues to advance
    before a new round of band procurement catalog including 35 varieties has been circulating in the industryAt the same time, the national level continues to be strong in terms of volume procurementDecember 19 last year, the General Office of the National Health and Reform Commission issued "on the further improvement of the state organization of drug centralized procurement of selected drugs equipped with the use of the notice", requiring attention to the procurement of selected varieties, the useAccording to the notice, the purchase of selected drugs with volume will not be controlled fees, drug proportion, one product two regulations and other restrictionsUnder the premise of rational use and ensuring the quality and safety of medical care, priority should be given to the use of selected drugsIn addition, the provincial health administrative departments are required to follow the agreed procurement volume reported in the region, to urge and guide medical institutions to timely equipped with the use of selected drugs, to ensure the completion of the contract on scheduleOn December 29 last year, the Joint Procurement Office of the State Organization for the Central Procurement and Use of Drugs issued the "National Drug Centralized Procurement Document" announcement that the purchase period was agreed upon1 home selection procurement period of 1 year, 2 to 3 home procurement period of 2 years, 4 to 6 home procurement period of 3 yearsGreat Wall Securities believes that this means that after 4 to 6 winning bids will monopolize the market for 3 years, in the procurement period other non-winning enterprises difficult to enter, or will gradually withdraw from the market, the industry pattern will continue to reshapein addition,, the second round of band purchase also agreed to the purchase volume: the first year of all varieties agreed to purchase volume according to the following rulesThe actual selected enterprises in the country are 1, 50% of the calculation base of the agreed procurement volume in the first year; 2 of the actual selected enterprises in the country are 60% of the calculated base for the first year's agreed procurement volume;, there are brokerage analysis that, on the whole, the new program continues the previous price-for-value thinking, the number of selected enterprises, the adjustment of the winning criteria, to avoid excessive price competition, encourage more enterprises to participate in consistent evaluation and band procurement, while the procurement volume and cycle changes, meaning that larger market share, longer cycle of non-selected enterprises can not participate in the adjustment of market competition pattern" does not participate in the band procurement, will have an impact on the future development of enterprisesAnd participate in the volume procurement, will also face new challenges"An industry source told reportersGuosheng Securities issued a research report that the amount of procurement is conducive to raw materials of the self-produced enterprisesWhen the price is the same, the protection of supply is the core consideration, whether it is the supply area, or sales volume, or even raw materials production, are to protect the supply of considerations, good raw materials preparation integration of enterprises, while the rules also encourage enterprises as soon as possible to carry out a consistent evaluationindustry pattern accelerated change
    Ping An Securities issued the research report that the volume of procurement to break the old pattern of interests, greatly save medical insurance fundsThe purchase of the "4 plus 7" band volume can save 5,988 million yuan in drug expenditure, a proportion of up to 76%The combined market size of the 25 varieties in the Alliance Area after the price reduction was not higher than 9.2 billion yuan, while the market size before the price reduction was 37.1 billion yuan, saving 27.8 billion yuanthe launch of the second round of band purchases also has a relationship with the share prices of listed companies in the industryAs of December 30, 2019, the share prices of 128 listed companies in the A-share biopharmaceutical sector fell, according to Tonghuashun datahowever, for the performance of the capital market, a pharmaceutical industry investor told reporters that the market for this volume of procurement had expected since August 2019, East China Pharmaceutical's share price has continued to adjust It is understood that the shortlisted amount of procurement of Acapo sugar tablets is currently the largest sales revenue of East China pharmaceutical pharmaceutical preparation products According to the IQVIA (Ai Kunwei, formerly known as Emmes IMS) database, the global sales of Acapo sugar preparation products in 2018 were $647 million, of which China's market sales were $549 million; In 2018, Bayer ag nourts accounted for 57.26% of China's Acapo sugar products, while China and East China accounted for 33.67 percent before that, Acapo sugar tablets into the band procurement has become the focus of the market In response to investorquestions, East China Pharma said that Acapo Sugar is a strategic core of the company, is important to the company, but not the company's products At present, the competitive landscape is more favorable to the company, in addition to the technical barriers of fermentation process, Acapo sugar raw material production capacity and cost is also the company's competitive advantage The market is somewhat over-worried about the impact of Aca's inclusion in the collection, and the company is ready to respond positively to the national harvest it is worth mentioning that the volume procurement will have an impact on the pharmaceutical market East China Medicine, with the promotion of the national collection policy, the company will be the existing related marketing and business service personnel to do internal diversion At present, the company's coverage in the grass-roots market has not yet reached the target, the company plans to reach more than 70% of the county-level hospitalcoverage In addition, the company has more than 20 varieties in the diabetes pipeline reserves, there are three innovative drugs and tumor, cardiovascular, super-resistant and other fields of varieties from the next year will be declared and listed, the follow-up still need to increase the marketing of innovative drugs and pharmaceutical service personnel to carry out the corresponding customer service work an industry insider told reporters that with the continuous promotion of the procurement of the amount, pharmaceutical representatives of pharmaceutical enterprises will also face adjustment, there will be more and more pharmaceutical manufacturers to adjust the marketing team.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.